These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20116834)

  • 41. Heparin-induced thrombocytopenia.
    Warkentin TE
    Dis Mon; 2005; 51(2-3):141-9. PubMed ID: 15900266
    [No Abstract]   [Full Text] [Related]  

  • 42. [Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].
    Kigawa I; Okamura Y; Fukuda S; Miyairi T
    Kyobu Geka; 2010 Jun; 63(6):442-5. PubMed ID: 20533732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of a pediatric patient on the Berlin Heart Excor ventricular assist device with argatroban after heparin-induced thrombocytopenia.
    Schmitz ML; Massicotte P; Faulkner SC; Bhutta AT; Johnson CE; Seib PM; Frazier EA; Fiser WP; Imamura M; Jaquiss RD
    ASAIO J; 2008; 54(5):546-7. PubMed ID: 18812751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN; Rice L; Bartholomew JR; Whelton A
    Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 47. Argatroban in adult extracorporeal membrane oxygenation.
    Johnston N; Wait M; Huber L
    J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S
    Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding.
    Sun X; Chen Y; Xiao Q; Wang Y; Zhou J; Ma Z; Xiang J; Chen X
    Nephrol Dial Transplant; 2011 Sep; 26(9):2954-9. PubMed ID: 21303963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
    Steinfeldt T; Rolfes C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Argatroban for anticoagulation during cardiopulmonary bypass in an infant.
    Dyke PC; Russo P; Mureebe L; Russo J; Tobias JD
    Paediatr Anaesth; 2005 Apr; 15(4):328-33. PubMed ID: 15787926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.
    Williamson DR; Boulanger I; Tardif M; Albert M; Grégoire G
    Pharmacotherapy; 2004 Mar; 24(3):409-14. PubMed ID: 15040656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia.
    Miyares MA
    Ann Pharmacother; 2015 Apr; 49(4):499. PubMed ID: 25762657
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Apr; 49(4):500. PubMed ID: 25762658
    [No Abstract]   [Full Text] [Related]  

  • 60. Heparin-induced thrombocytopenia in essential thrombocytosis.
    Murawaki A; Nakayasu H; Doi M; Suzuki-Kinoshita K; Asai Y; Omura H; Nakashima K
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e1-5. PubMed ID: 22425438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.